drugset / Trial / NCT03577886
Safety and Tolerability of CDX-6114 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety and tolerability of an oral solution of CDX-6114 when administered as a single dose in healthy volunteers.
Timeline
- Start
- 2018-07-04
- Primary completion
- 2018-08-21
- Completion
- 2018-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CDX-6114 | Unknown | 0.225 g | Oral |
| Subject | CDX-6114 | Unknown | 0.75 g | Oral |
| Subject | CDX-6114 | Unknown | 2.25 g | Oral |
| Subject | CDX-6114 | Unknown | 7.5 g | Oral |
Indications
No indication recorded.